[Examination for osteoporosis in patients with chronic obstructive pulmonary disease]

Ugeskr Laeger. 2018 Oct 1;180(40):V12170934.
[Article in Danish]

Abstract

Patients with chronic obstructive pulmonary disease (COPD) are at risk of developing osteoporosis, as the COPD in itself as well as continued smoking and treatment with systemic corticosteroid all increase the risk of developing osteoporosis. Other risk factors for osteoporosis are low vitamin D levels, malnutrition and physical inactivity. All patients who have risk factors in the form of severe COPD, and all patients with COPD in active treatment with systemic corticosteroid and/or other risk factors should be examined with a DEXA-scan. Treatment of osteoporosis in patients with COPD does not differ from general recommendations.

Publication types

  • Review

MeSH terms

  • Absorptiometry, Photon
  • Bone Density / drug effects
  • Comorbidity
  • Critical Pathways
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / adverse effects
  • Glucocorticoids / therapeutic use
  • Humans
  • Malnutrition / complications
  • Osteoporosis* / diagnosis
  • Osteoporosis* / epidemiology
  • Osteoporosis* / etiology
  • Osteoporosis* / therapy
  • Pulmonary Disease, Chronic Obstructive / complications*
  • Pulmonary Disease, Chronic Obstructive / drug therapy
  • Pulmonary Disease, Chronic Obstructive / epidemiology
  • Risk Factors
  • Smoking / adverse effects
  • Vitamin D Deficiency / complications

Substances

  • Glucocorticoids